EU Indication Restricted For Novartis's Newly Approved Piqray

Patients Previously Treated With CDK 4/6 Inhibitors Are Excluded

 
• By Maureen Kenny
  
Drug Review Profile regular column
There was disagreement among EU regulators over what indication should be allowed • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography